In brief
Syria's descent into becoming a narcotics hub highlights the intersection of conflict and drug trafficking, revealing the powerful forces involved behind its distribution.
Rebel fighters in Syria recently discovered significant stockpiles of Captagon, illuminating the country's rise as a primary producer and exporter of the illegal stimulant. Originally developed in Germany as fenethylline in the 1960s for medical purposes, Captagon was banned in the 1980s due to its addictive potential and severe side effects, including psychosis and suicidal tendencies. Today, the illicit version found in Syria is a synthetic stimulant that often contains a cocktail of amphetamines, caffeine, and other fillers. In recent developments, fighters uncovered these stockpiles in a warehouse on the outskirts of Damascus, leading to discussions around the Assad regime's involvement in the drug trade. Reports indicate that relatives and associates of Bashar al-Assad have orchestrated a narcotics-trafficking network that has eclipsed more legitimate exports, thus branding Syria a narcostate.Despite its dubious status, Captagon commands high prices on the street. The per-pill cost ranges from $3 to $20, while it is produced at a fraction of this in Syria, underscoring the lucrative nature of this illicit trade. With the ongoing changes in leadership, questions loom over whether or not new authorities can or will take effective action to mitigate the drug trade's grip on the nation. The challenges remain formidable, not only in terms of curtailing an entrenched narcotics economy but also in addressing the intricate web of relationships that has developed between state actors and the drug trade within the conflict-torn nation.
